DBV Technologies (DBVT) Interest Expenses (2018 - 2026)

DBV Technologies (DBVT) posted quarterly Interest Expenses of $8.9 million for Q2 2026, down 2.38% year-on-year from $9.1 million in Q2 2025, and up 25.35% on a QoQ basis from $7.1 million in Q1 2026.

DBV Technologies (DBVT) Interest Expenses (2018 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Interest Expenses for 9 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

  • Quarterly Interest Expenses fell 2.38% year-over-year to $8.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.9 million (down 2.38% YoY) and the FY2025 annual result came in at $365.8 million, up 12.52% from the prior year.
  • Interest Expenses rose to $8.9 million in Q2 2026 per DBVT's latest filing, from $7.1 million in the prior quarter.
  • Over the last five years, Interest Expenses for DBVT reached as high as $9.1 million in Q2 2025 and fell as low as -$88000.0 in Q4 2024.
  • A 5-year average of $3.5 million and a median of $1.7 million in 2023 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2022 — Interest Expenses surged 1847.06% — and 2024, when it plunged 116.12%.
  • Year by year, Interest Expenses stood at $662000.0 in 2022, then fell by 17.52% to $546000.0 in 2023, then sank by 116.12% to -$88000.0 in 2024, then soared by 398.86% to $263000.0 in 2025, then soared by 3284.03% to $8.9 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $8.9 million, $7.1 million, and $263000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 DBV Technologies 267.50 Mn 92.60 Mn - 8.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.90 Mn
Jun 30, 2026 8.90 Mn
Mar 31, 2026 7.10 Mn
Mar 31, 2026 7.10 Mn
Dec 31, 2025 263,000.00
Dec 31, 2025 263,000.00
Sep 30, 2025 9.02 Mn
Sep 30, 2025 9.02 Mn
Jun 30, 2025 9.12 Mn
Jun 30, 2025 9.12 Mn
Mar 31, 2025 8.68 Mn
Mar 31, 2025 8.68 Mn
Dec 31, 2024 -88,000.00
Dec 31, 2024 -88,000.00
Sep 30, 2024 9.08 Mn
Sep 30, 2024 9.08 Mn
Jun 30, 2024 1.69 Mn
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.91 Mn
Mar 31, 2024 1.91 Mn